An observational study in Sensory Hearing Loss, sponsored by Advanced Bionics AG. Completed at 1 site in Switzerland. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2024-08-23.
Sponsored by Advanced Bionics AG (part of Sonova AG) · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 28 studies in Hearing Loss, Sensorineural by Sonova AG — 4 open to participants now, 4 under way, none of them phase 3. Hearing Loss, Sensorineural · Sonova AG.
Among the 28 studies in Hearing Loss, Sensorineural by Sonova AG, this one is the only one that started in 2015, is one of 7 observational ones, and was the 1st registered.
348 studies on the registry are indexed under Hearing Loss, Sensorineural; 103 are open to participants now.
Browse Hearing Loss, Sensorineural studies →4 of the 28 studies in Hearing Loss, Sensorineural by Sonova AG are open now, in 8 countries. Recruiting first, the newest first:
Advanced Bionics AG · Sites in France
Ages 18+
Advanced Bionics AG · Sites in Belgium, France, Germany and 4 more countries
Ages 18+
Advanced Bionics AG · Sites in Germany
Sonova AG · Sites in United States
Ages 18+
By country, each count listing its studies:
Of the 70 Hearing Loss, Sensorineural studies recruiting now, 39 (56%) set no upper age limit and 19 (27%) stop at 75 or younger; 26 take children under 18; 17 take healthy volunteers.
This study: 18 Years to 80 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
28 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 1 · Phase 3 1
First in 2015; this study’s year is marked. 1 started in 2015.
This study's enrollment of 4 is below the median of 70 across 86 observational studies indexed under Hearing Loss, Sensorineural.
Median enrollment 20 across the 21 interventional studies, 37 across the 7 observational. Of the 24 that completed or were terminated, 13 (54%) have results posted.
This tab as a report to print or save as PDF → With an account.
This study is registered under Advanced Bionics AG, one of the names counted as Sonova AG. Under that name alone:
Advanced Bionics AG is the lead sponsor of 12 studies on the registry; 3 are open to participants now.
2 of the studies in Hearing Loss, Sensorineural by Sonova AG that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06894303Advanced Bionics AGEvaluation of Remote Programming of Cochlear Implants in Routine Cochlear Implant Follow-up | 2026-12 |
| NCT06268340Advanced Bionics AGHearing and Structure Preservation Via ECochG | 2026-12-31 |
Add all 2 to your calendar (.ics) → With an account.
Among the 28 studies in Hearing Loss, Sensorineural by Sonova AG, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of the study is to determine the benefit in speech intelligibility of the BBF and the MBF compared to an omni-directional microphone in different noise conditions. Secondary objective is to determine if there is a subjective preference for one of the microphone settings in different noise conditions.
Study participants will be invited for two appointments. In the first appointment test will be performed inside the lab (lab measurements) and outside the lab (real life measurements) and in the second appointment test will be performed in the lab. In between appointments participants are asked to try the Naida CI Q90 at home and in their familiar surroundings for 2-4 weeks (home trial).
Lab measurements:
The Oldenburg Sentence Test will be used as speech signal to determine the speech reception threshold (SRT) for each background noise with an adaptive procedure. The overall level of the noise will be held constant while the level of the speech signal will be adapted depending on the words understood correctly for each sentence.
In addition to the objective speech intelligibility measurements the three microphone settings will also be assessed subjectively. For each background noise scenario the Oldenburg sentences will be presented successively from the frontal loudspeaker. The experimenter will switch between two programs on the participant's processor who then compares the two different microphone settings of these programs. Three paired comparisons will be performed: omni-directional vs. MBF, omni-directional vs. BBF and MBF vs. BBF. The comparisons will be made with regards to speech intelligibility, noise suppression and overall preference in each situation.
Real life measurements:
Even though the results obtained in the lab present a good approximation to real-life performance both beam former options should also be tested outside the lab and in everyday life. In a guided tour the experimenter will take the study participant to noisy places in Zürich, if possible to the same or similar places in which the lab recordings were made. The same paired comparisons as in the lab will be performed with the experimenter talking to the participant or reading a story aloud.
Home trial:
Finally, the study participant should evaluate all three microphone settings for 2-4 weeks during activities in their familiar surroundings, i.e. having a conversation with one or more persons at home, in the tram, in a restaurant, attending a meeting at work, etc. Subjective feedback will be collected in a questionnaire.
Instead of collecting subjective feedback in paper form the questions can be presented on a SmartPhone (Motorola Moto G) screen for those participants able to use a SmartPhone (Motorola Moto G). In that way the participant can answer the questions when he finds himself in a certain listening situation. Such a solution might be more comfortable than a paper questionnaire for some participants. An App for a mobile questionnaire called MobEval already exists from Phonak and will be used in this study. Participants will receive loaner SmartPhones (Motorola Moto G).
See below
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Each study participant will use an Advacned Bionics Naida CI Q90 loaner processor during the course of the study, an Advanced Bionics MyPilot remote control and- if applicable- a SmartPhone. the processors will be programmed with SoundWave and BEPSnet.
speech reception thresholds (SRT) assessment with audiological measures (omni)
The primary study outcome are speech reception thresholds (SRT) measured with omni-directional microphone setting
Time frame: 10 months
speech reception thresholds (SRT) assessment with audiological measures (BBF)
The primary study outcome are speech reception thresholds (SRT) measured with BBF microphone setting
Time frame: 10 months
speech reception thresholds (SRT) assessment with audiological measures (MBF)
The primary study outcome are speech reception thresholds (SRT) measured with MBF microphone setting
Time frame: 10 months
paired comparisons assessment with scaling (speech intelligibility)
The main secondary outcome are paired comparisons which will be performed in the lab and on a guided tour outside the lab. The comparisons will be made with regards to speech intelligibility.
Time frame: 10 months
paired comparisons assessment with scaling (noise suppression)
The main secondary outcome are paired comparisons which will be performed in the lab and on a guided tour outside the lab. The comparisons will be made with regards to noise suppression.
Time frame: 10 months
paired comparisons assessment with scaling (overall)
The main secondary outcome are paired comparisons which will be performed in the lab and on a guided tour outside the lab. The comparisons will be made with regards to overall preference in each situation.
Time frame: 10 months
Ran from Sep 2015 to primary completion in Oct 2016, 13 months.
Of 42 observational studies under Hearing Loss, Sensorineural, half reached primary completion within 49 months of starting (the median), counting those still running; a quarter within 13. This study's 13 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.